Please assess the completion status of the following clinical trial:

Trial Title: Bunionectomy Study (0000-063)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Patient is a man or woman between 18 and 65 years of age~* For Women of Child-bearing potential: woman who is currently not pregnant not nursing and who is willing to use a medically acceptable method of birth control from the time after the screening visit until completion of the follow-up visit~* Patient is scheduled to have a bunionectomy~* Patient must be willing to stay at the study site throughout the 48-hour observation period following surgery and is willing to complete a 2-week follow up~* Patient is capable of operating a Patient Controlled Analgesia device~Exclusion Criteria:~* Patient is being treated for a disease and has not been on a stable dose of medication for at least 2 weeks prior to surgery~* Patient has used or intends to use any of the medications that are prohibited by the protocol, which could interfere with the evaluation of the study drugs~* Patient has an estimated creatinine clearance of \< or = 60 mL per min~* Patient has a history of drug abuse or dependence, or patient has a positive urine drug screen~* Patient has a condition that prevents clear communication concerning pain perception (such as diabetic neuropathy, peripheral neuropathy, etc.)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Arm 1: Pregabalin 300 mg (Type: ACTIVE_COMPARATOR): None
- Arm 2: naproxen sodium 550 mg (Type: ACTIVE_COMPARATOR): None
- Arm 3: Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).